PYELOCYSTITIS

This adverse event was reported 12 times

PYELOCYSTITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERTUGLIFLOZIN AND SITAGLIPTIN 1 0.0083
1 CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 1 0.0004
2 VALPROIC ACID 2 0.0001
3 DOXORUBICIN HYDROCHLORIDE 1 0.0000
4 DICLOFENAC SODIUM 1% 1 0.0000
5 DICLOFENAC SODIUM TOPICAL GEL, 1% 1 0.0000
6 TERIFLUNOMIDE 1 0.0000
7 MONTELUKAST SODIUM 2 0.0000
8 OCRELIZUMAB 1 0.0000
9 DABIGATRAN ETEXILATE MESYLATE 1 0.0000
See all drugs enriched for association with PYELOCYSTITIS

PYELOCYSTITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
1 Mood Stabilizer [EPC] 2 0.0000
2 Anti-epileptic Agent [EPC] 2 0.0000
3 Interferon beta [EPC] 1 0.0000
4 Thiazide Diuretic [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
See all drug classes enriched for association with PYELOCYSTITIS